Mersana Therapeutics Inc. (MRSN)

Market is closed

Hedge Fund Popularity

13F filing is ongoing

Hedge Fund Holdings
Filing Period:
Last update:
No. Hedge Fund Shares Value (x$1000) Activity % Port
1.
OrbiMed Advisors

Samuel Isaly

9,011,437 $41,633 +89% 0.75%
2.
VenBio Select Advisor

Kurt Von Emster

7,550,000 $34,881 +12% 0.68%
3.
Millennium Management

Israel Englander

4,382,701 $20,248 -11% 0.01%
4. 4,299,297 $19,863 1.99%
5.
Rock Springs Capital Management

Kris Jenner, Gordon Bussard, Graham Mcphail

4,075,958 $18,831 +9% 0.54%
Insider Trading: Purchases See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$3.20 14,760 Director 8,663,673 2022-06-02 Filing
$3.28 80,759 Director 8,648,913 2022-05-31 Filing
$3.19 75,000 Director 8,568,154 2022-05-26 Filing
$3.18 90,155 Director 8,493,154 2022-05-25 Filing
$3.29 100,000 Director 8,402,999 2022-05-24 Filing
Insider Trading: Sales See All
Insider Price Amount Relationship Remaining Holdings Date Form 4
$7.10 1,879 Officer 4,371 2022-08-17 Filing
$3.69 3,948 Officer 9,302 2022-04-26 Filing
$5.92 4,741 Officer 131,234 2022-01-18 Filing
$5.92 1,982 Officer 3,371 2022-01-18 Filing
$6.81 5,527 Officer 12,973 2021-12-01 Filing
Institutional Investors' Holdings
Filing Period:
No. Name Shares Value (x$1000) % Port
1. 539,703 $2,493,428 0%
2. 491,048 $2,269,000 0.03%
3. 88,374 $408,288 0%
4. 8,881,019 $41,030 0%
5. 8,663,673 $40,026 4.69%
News See All